3-(Acetylsulfanyl)-2-methylpropanamide
- $218 - $308
- Product name: 3-(Acetylsulfanyl)-2-methylpropanamide
- CAS: 909027-82-3
- MF: C6H11NO2S
- MW: 161.22
- EINECS:
- MDL Number:MFCD02755772
- Synonyms:3-(Acetylsulfanyl)-2-methylpropanamide;Ethanethioic acid, S-(3-amino-2-methyl-3-oxopropyl) ester;S-(3-Amino-2-methyl-3-oxopropyl) ethanethioate
4 prices
Selected condition:
Brand
- Apolloscientific
- Crysdot
- Matrix Scientific
- SynQuest Laboratories
Package
- 500mg
- 1g
- ManufacturerApolloscientific
- Product numberOR311103
- Product description3-(Acetylsulfanyl)-2-methylpropanamide
- Packaging500mg
- Price$218
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD13001520
- Product descriptionS-(3-Amino-2-methyl-3-oxopropyl)ethanethioate 97%
- Packaging1g
- Price$308
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number118658
- Product description3-(Acetylsulfanyl)-2-methylpropanamide >95%
- Packaging500mg
- Price$261
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number8169-1-09
- Product description3-(Acetylsulfanyl)-2-methylpropanamide
- Packaging500mg
- Price$240
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Apolloscientific | OR311103 | 3-(Acetylsulfanyl)-2-methylpropanamide | 500mg | $218 | 2021-12-16 | Buy |
Crysdot | CD13001520 | S-(3-Amino-2-methyl-3-oxopropyl)ethanethioate 97% | 1g | $308 | 2021-12-16 | Buy |
Matrix Scientific | 118658 | 3-(Acetylsulfanyl)-2-methylpropanamide >95% | 500mg | $261 | 2021-12-16 | Buy |
SynQuest Laboratories | 8169-1-09 | 3-(Acetylsulfanyl)-2-methylpropanamide | 500mg | $240 | 2021-12-16 | Buy |
Properties
Boiling point :321.7±25.0 °C(Predicted)
Density :1.152±0.06 g/cm3(Predicted)
pka :16.06±0.50(Predicted)
Density :1.152±0.06 g/cm3(Predicted)
pka :16.06±0.50(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|